Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Meso-Zeaxanthin and Omega-3 are closely matched across evidence, studies, and safety.
Verdict
Likely helps
3 of 3 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
18 of 27 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Meso-Zeaxanthin and Omega-3 have evidence — compare verdict strength side-by-side.
10mg daily (often in combination with lutein and zeaxanthin)
With a fat-containing meal, Any time of day
Meso-zeaxanthin with lutein and zeaxanthin (MPOD formula)
2-3g combined EPA+DHA daily
With meals containing fat
Triglyceride form fish oil
8-24 weeks
12-24 weeks
Ongoing
4-8 weeks
2-4 weeks
Immediate
4-12 weeks
Effect of Antioxidant Supplementation on Macular Pigment Optical Density and Visual Functions: Network Meta-Analysis
Advances in Nutrition (2024) · Meta analysis · n=3159
Network meta-analysis of RCTs
The Effect of Lutein/Zeaxanthin Intake on Human Macular Pigment Optical Density: A Systematic Review and Meta-Analysis
Advances in Nutrition (2021) · Meta analysis · n=3189
46 studies with 3189 participants analyzed
Carotenoids in the Management of Glaucoma: A Systematic Review of the Evidence
Nutrients (2021) · Systematic review
A comprehensive literature search was conducted in three databases (PubMed, Cochrane Library, and Web of Science) and 20 records were identified for screening.
Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
The New England journal of medicine (2019) · Rct · n=25871
During a median follow-up of 5.3 years, a major cardiovascular event occurred in 386 participants in the n-3 group and in 419 in the placebo group (hazard ratio, 0.92; 95% confidence interval [CI], 0.80 to 1.06; P=0.24).
Omega-3 fatty acids for intermittent claudication
The Cochrane database of systematic reviews (2024) · Meta analysis · n=1830
Omega-3 compared with a control may have little to no effect on ankle-brachial index (MD -0.02, 95% CI -0.08 to 0.04; 3 studies, 168 participants; very low-certainty evidence).
A systematic review and meta-analysis of the omega-3 fatty acids effects on brain-derived neurotrophic factor (BDNF)
Nutritional neuroscience (2024) · Meta analysis · n=587
The present systematic review and meta-analysis indicate the efficacy of omega-3 FAs in increasing the serum concentration of BDNF.
Based on meta-analysis of 46 studies with 3189 participants confirming dose-response relationship at 5-20mg/day. Effect measured as increase in macular pigment optical density. Conservative estimates given variable individual response rates.
Based on multiple meta-analyses showing EPA-dominant formulas >1g/day most effective. Effects plateau around 2-2.5g. Adjunctive use with antidepressants shows better outcomes than monotherapy.
AI-estimated from published studies. Interpret as directional guidance.
Both Meso-Zeaxanthin and Omega-3 are closely matched — the best choice depends on your specific health goals.
No known interactions between Meso-Zeaxanthin and Omega-3 have been documented in our database. However, always consult a healthcare provider before combining supplements.